Henry R. Wolfe

Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA.

Targeted Diagnostics & Therapeutics, Inc. operates as a biotechnology company. The firm develops molecular diagnostics and therapeutics for the diagnosis and treatment of colorectal cancer and other gastrointestinal diseases. Its activities include research and development projects in in-vitro diagnostics and imaging agents, receptor-based therapeutics, and cancer vaccines; and a clinical laboratory for testing blood and tissues for metastatic colorectal cancer for patients. The company was founded by Harry A. Arena in August 1994 and is headquartered in West Chester, PA.